コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 F. tularensis DNA in buffer or CFU of F. tularensis was
3 de from bovine pericardial tissue that is 14-F compatible with a motorized delivery system allowing f
22 1-[(18)F]fluoro-2,5-anhydro-mannitol (1-[(18)F]FDAM), 2-deoxy-2-[(18)F]fluoro-d-glucose (2-[(18)F]FDG
23 f 1-deoxy-1-[(18)F]fluoro-d-fructose (1-[(18)F]FDF), 6-deoxy-6-[(18)F]fluoro-d-fructose (6-[(18)F]FDF
24 ro-d-fructose (6-[(18)F]FDF), 1-deoxy-1-[(18)F]fluoro-2,5-anhydro-mannitol (1-[(18)F]FDAM), 2-deoxy-2
26 The final study population included 176 (18)F-FDG PET/CT studies in 153 patients (107 men, 46 women;
27 metabolism, exemplified by fluorine 18 ((18)F) fluorodeoxyglucose (FDG) positron emission tomography
30 ), 2-deoxy-2-[(18)F]fluoro-d-glucose (2-[(18)F]FDG), and 6-deoxy-6-[(18)F]fluoro-d-glucose (6-[(18)F]
31 dro-mannitol (1-[(18)F]FDAM), 2-deoxy-2-[(18)F]fluoro-d-glucose (2-[(18)F]FDG), and 6-deoxy-6-[(18)F]
32 igate whether sex influences 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake and tissue distribu
33 irst (18)F-DCFPyL (2-(3-{1-carboxy-5-[(6-(18)F-fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-p e
34 (4-(((S)-4-carboxy-2-((S)-4-carboxy-2-(6-(18)F-fluoronicotinamid o)butanamido)butanamido)methyl)pheny
35 , 6-deoxy-6-[(18)F]fluoro-d-fructose (6-[(18)F]FDF), 1-deoxy-1-[(18)F]fluoro-2,5-anhydro-mannitol (1-
36 nd 6-deoxy-6-[(18)F]fluoro-d-glucose (6-[(18)F]FDG) was studied in EMT6 cells, tumors, and muscle and
37 ro-d-fructose (1-[(18)F]FDF), 6-deoxy-6-[(18)F]fluoro-d-fructose (6-[(18)F]FDF), 1-deoxy-1-[(18)F]flu
38 d-glucose (2-[(18)F]FDG), and 6-deoxy-6-[(18)F]fluoro-d-glucose (6-[(18)F]FDG) was studied in EMT6 ce
42 hly selective sigma-1 receptor PET agent (18)F-6-(3-fluoropropyl)-3-(2-(azepan-1-yl)ethyl)benzo[d]thi
43 , specifically for B-(18)F, Si-(18)F, Al-(18)F, and iodine (III)-mediated radiofluorination via the s
46 Although (18)F-FDG, (18)F-PBR111, and (18)F-AV45 all detected pathologic alterations between TG an
48 BAT, cold stress reduces blood flow and (18)F-FDG uptake in subcutaneous WAT, indicating that the ph
49 es in caudate and putamen, p<0.0001) and (18)F-FDOPA uptake (in caudate: age </=50 years, p=0.0002; a
50 s the concordance between (18)F-FDHT and (18)F-FES PET and tumor AR and ER expression measured immuno
51 ere scanned with [(11)C]carfentanil and [(18)F]fluorodopa positron emission tomography using a high-r
53 beling methodologies, specifically for B-(18)F, Si-(18)F, Al-(18)F, and iodine (III)-mediated radiofl
54 e of this study was to describe baseline (18)F-FDG PET voxel characteristics in pediatric diffuse int
55 im was to assess the concordance between (18)F-FDHT and (18)F-FES PET and tumor AR and ER expression
56 mine transporter binding, VMAT2 binding, (18)F-FDOPA uptake, and serotonin transporter binding in mul
57 ents underwent a preoperative whole-body (18)F-FDG PET/CT scan at 1 h (standard examination) and an a
61 based on early evaluation of response by (18)F-FDG PET in patients in the Dutch GIST registry treated
62 enty-three GBM patients were assessed by (18)F-fluoromisonidazole ((18)F-FMISO) PET and conventional
64 95.2% and 77.8% on standard and delayed (18)F-FDG PET/CT for an SUVmax cutoff of greater than 1.32 a
67 objective of this study was to evaluate (18)F-AV-1451 binding with full kinetic analysis using a met
68 ) The goal of this study was to evaluate (18)F-FASu as a specific gauge for system xC(-) activity in
69 This article reviews the data evaluating (18)F-FDG PET quantification approaches in lung diseases, fo
71 en (PSMA)-targeted PET/CT tracers, first (18)F-DCFPyL (2-(3-{1-carboxy-5-[(6-(18)F-fluoro-pyridine-3-
72 (18)F-labeled fluoroazomycinarabinoside ((18)F-FAZA) is a PET biomarker for noninvasive identificatio
73 re assessed by (18)F-fluoromisonidazole ((18)F-FMISO) PET and conventional and perfusion MRI before s
74 ences 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake and tissue distribution in mouse models of
75 ntly observed in nonspecific tissues for (18)F-4FMFES, notably a 4-fold decrease in blood-pool activi
76 A total of 13 articles (11 studies for (18)F-FDG PET-CT and 2 for LS), met the inclusion criteria.
78 rence region was significantly lower for (18)F-FPSCH (range, 1.41-2.62) than for (18)F-FESCH (range,
79 acteristic curve (AUC, in g/mL. min) for (18)F-FTT was assessed in normal mouse organs before and aft
80 by 40% for (11)C-raclopride, by 52% for (18)F-MNI-659, by 28% for (11)C-NNC, and by 11% for (11)C-MD
82 alog [(18)F]fluoro-2-deoxy-2-d-glucose ([(18)F]-FDG) is commonly used in PET/CT that is retained by m
83 iagnosing DLBCL in the clinic; however, [(18)F]FDG-PET often faces difficulty in differentiating mali
86 However, no significant differences in (18)F-FDG-derived SUVs were observed between different grade
88 metastases predominantly show increased (18)F-FET uptake, and only a third of metastases < 1.0 cm we
89 nodes of nonsurvivors showed increased [(18)F]-FDG uptake by day 4 postinfection with minimal lymph
90 Moribund NHPs demonstrated increased [(18)F]-FDG uptake in bone marrow 4 days postinfection compar
93 ) radioligands using the copper-mediated (18)F-fluorination of aryl boron reagents with (18)F-fluorid
100 hed studies reporting the performance of (18)F-FDG PET or (18)F-FDG PET/CT in patients with suspected
101 we investigated the diagnostic value of (18)F-FDG PET/CT in chronic Q fever at diagnosis and during
102 encephalitides, comparing the utility of (18)F-FDG PET/CT versus conventional brain imaging with MRI.
104 ves, slope, and tumor-to-brain ratios of (18)F-FET uptake (18-61 min after injection) were evaluated
105 data, we evaluated the repeatability of (18)F-FLT PET as part of a multicenter trial involving patie
111 ytoma) received 148-444 MBq (4-12mCi) of (18)F-MFBG intravenously followed by serial whole-body imagi
113 Additionally, the biodistribution of [(18)F]FPTMP in a nonhuman primate shows low background in ma
114 d the reproducibility of their impact on (18)F-FDG PET quantification in patients with non-small cell
118 alterations between TG and WT mice, only (18)F-AV45 could detect an effect of BACE inhibitor treatmen
119 ting the performance of (18)F-FDG PET or (18)F-FDG PET/CT in patients with suspected paraneoplastic s
121 end clinical transfer of the radioligand (18)F-PSMA-1007 for use as a diagnostic PET tracer in presta
122 s article provides an overview of recent (18)F-labeling methodologies, specifically for B-(18)F, Si-(
123 o)-p entanedioic acid) and more recently (18)F-PSMA-1007 (((3S,10S,14S)-1-(4-(((S)-4-carboxy-2-((S)-4
127 hodologies, specifically for B-(18)F, Si-(18)F, Al-(18)F, and iodine (III)-mediated radiofluorination
128 e technique was assessed in simultaneous (18)F-FDG PET/MR scans of a canine model of myocardial infar
129 uman primate (NHP) PET imaging studies, [(18)F]8 showed rapid brain uptake and high target specificit
131 igh target specificity, indicating that [(18)F]8 is a promising PDE4B-preferring radioligand for clin
137 xyglucose positron emission tomography ([(18)F]FDG-PET) imaging has an essential role in diagnosing D
138 udies using (18)F-fluoro-ethyl-tyrosine ((18)F-FET) (n = 31) and (68)Ga-DOTANOC (n = 7) and studies o
140 LC, we recruited all those who underwent (18)F-FDG PET/CT for clinical reasons at our institution bef
141 tudy of all adult patients who underwent (18)F-FDG PET/CT in search of a focal source of infection wa
142 Overall, fourth and subsequent follow-up (18)F-FDG PET/CT scans resulted in change in management in 3
146 have previously reported that PET using (18)F-fluoride (NaF PET) for assessment of osseous metastati
147 were included: brain tumor studies using (18)F-fluoro-ethyl-tyrosine ((18)F-FET) (n = 31) and (68)Ga-
150 ET/CT imaging was performed to visualize (18)F-FLT biodistribution and to determine pharmacokinetics.
151 only a third of metastases < 1.0 cm were (18)F-FET-negative, most likely because of scanner resolutio
155 ethod for early response evaluation with (18)F-FDG PET/CT performed most optimally for the prediction
156 associated with pTR, in 82 patients with (18)F-FDG-avid nodes before NAC we observed mNR in 10 (12.2%
158 e have previously reported that PET with (18)F-fluoride (NaF PET) for assessment of osseous metastati
162 ells detected by a clinically applicable (19)F MRI method correlated with the BLI findings, which poi
163 d with the BLI findings, which points to (19)F MRI as a reliable method with which to track ASCs afte
166 d seventy-eight consecutive CC patients (706 F) were enrolled (FC 62.5%, IBS-C 31.3%, NRC 6.2%).
169 f 2 or more subtypes, including subtypes A1, F, G, H, J, and K and unclassified fragments, including
170 is responsible for attaching the virus to an F-pilus and delivering the viral genome into the host du
171 id-beta insult caused cofilin activation and F-actin remodeling and decreased microtubule dynamics in
172 ively targeting mitochondria, lysosomes, and F-actin demonstrate low toxicity and enable stimulated e
173 microscopy to analyze nuclear morphology and F-actin rearrangements during the initiation, progressio
174 tput multi-task model we observed an average F-score improvement of 0.8% when compared to the single-
177 ne candidate and that the expression of both F and G proteins of AMPV-C induces a protective response
178 selected for this study were fruit-to-bunch (F/B), shell-to-fruit (S/F), kernel-to-fruit (K/F), mesoc
179 These results suggest that the rLS/AMPV-C F&G recombinant virus is a safe and effective bivalent v
180 An unprecedented intermolecular aliphatic C-F...H-C interaction was observed in the X-ray crystal st
182 previous observations, we suggest that CENP-F might act as a transporter of mitochondria and other c
184 he initiator caspase dronc triggers cortical F-actin dismantling, enabling the glands to stretch as t
185 ents TRF1 from binding to Fbx4, an Skp1-Cul1-F box E3 ligase subunit, thereby alleviating proteasomal
186 cruitment of PIF3-EBFs to the core SKP1-CUL1-F box protein (SCF) scaffold is facilitated by light sig
190 n of the TJ-associated ZO-1 and cytoskeletal-F-actin proteins, correlated with modulation of hepatic
191 ion repair (TC-NER) (category 1: XP-A, B, D, F, and G) and preserved TC-NER (category 2: XP-C, E, and
192 In the case-crossover analysis, a 5 degrees F increase during the week preceding delivery was associ
195 the parasite cytosol and labels an extensive F-actin network that connects parasites within the paras
198 des a 139-amino-acid protein containing five F-actin-binding sites and two G-actin-binding sites, and
202 ics (TPs), furan compounds (HMF and furfural F) and cytoprotective/cytotoxic effects upon Caco-2 cell
203 reviously as a vector expressing RSV fusion (F) protein to confer bivalent protection against RSV and
208 cluding use of either peptide:N-glycosidases F and A (PNGase F and A) or anhydrous hydrazine to cleav
210 tuin-1 small interfering RNA prevented hnRNP F stimulation of Foxo3alpha and downregulation of acetyl
213 esigned and characterized a recombinant hRSV F protein, called Pre-F-GCN4t, stabilized in a pre-F con
215 with high confidence with chloroplast HSP22E/F under heat stress thus revealing chloroplast processes
217 sted by a remarkable genomic conservation in F. acidiphilum Y(T) variants from geographically distant
219 osing activated atrophic pathways, including F-box protein 32 (Fbxo32), which encodes atrogin-1.
223 B), shell-to-fruit (S/F), kernel-to-fruit (K/F), mesocarp-to-fruit (M/F), oil per palm (O/P) and oil-
224 Encoded on CenA, C1-specific K44-KIR2DP1(F) were stronger receptors than the attenuated C2-specif
225 than the attenuated C2-specific T44-KIR2DP1(F) encoded on CenB The last common ancestor of humans an
228 kernel-to-fruit (K/F), mesocarp-to-fruit (M/F), oil per palm (O/P) and oil-to-dry mesocarp (O/DM).
229 s to combinatorially increase Mical-mediated F-actin disassembly, cellular remodeling, and repulsive
232 degrees C in the presence of (0.4 mM) NaBAr(F)4 as compared with a very slow reaction at 125 degrees
234 in 2015 would increase the average national F&V consumption by 7% for 1 y and prevent approximately
235 ed on the standard enthalpy change (DeltaH(o)F=-8.67kJ.mol(-1)), while microcalorimetry showed an ent
241 d activation of the PI3K, and recruitment of F-actin and of the actin-branching protein cortactin.
242 n maintaining the morphological structure of F-actin and in protein transport, loss of this function
249 ither peptide:N-glycosidases F and A (PNGase F and A) or anhydrous hydrazine to cleave the N-glycans
250 ecognizes site II on both the pre-F and post-F proteins, is restricted to prophylaxis in neonates at
251 in (F) of RSV in either its postfusion (post-F) or prefusion (pre-F) conformation is a target for neu
252 he prefusion (pre-F) to the postfusion (post-F) state at the time of virus-host cell membrane fusion.
254 an attenuated rHPIV1 vector expressing a pre-F-stabilized form of RSV F demonstrated promising immuno
257 er its postfusion (post-F) or prefusion (pre-F) conformation is a target for neutralizing antibodies
258 jor structural shift from the prefusion (pre-F) to the postfusion (post-F) state at the time of virus
260 ab, which recognizes site II on both the pre-F and post-F proteins, is restricted to prophylaxis in n
264 ed to express either the RSV fusion protein (F) or the RSV major attachment glycoprotein (G) between
266 or TIRF microscopy of in vitro reconstituted F-actin networks, we observed and characterized two dist
267 ivate Evaporative Cooling, which uses Relief-F feature selection and random forest classification.
268 utations (DS-Cav1), and we also modified RSV F codon usage to have a lower CpG content and a higher l
269 or expressing a pre-F-stabilized form of RSV F demonstrated promising immunogenicity and should be fu
274 were fruit-to-bunch (F/B), shell-to-fruit (S/F), kernel-to-fruit (K/F), mesocarp-to-fruit (M/F), oil
276 RANSPORT INHIBITOR RESPONSE1/AUXIN SIGNALING F-BOX PROTEIN (TIR1/AFB) family are known auxin receptor
278 ctase, alkyl hydroperoxide reductase subunit F (AhpF), catalyzes the rapid reduction of the redox-act
282 T-negative patients, 5-year PFS rates in the F group were 99.0% versus 87.1% (HR, 15.8; 95% CI, 3.8 t
283 quires septin-dependent reorientation of the F-actin cytoskeleton at the base of the infection cell,
285 .1 mice to an I-Ab-associated epitope of the F-MuLV envelope protein is dominated by clones expressin
286 id at POmega, which enabled them to open the F pocket and expose their C-terminal extension into the
287 odium distachyon (Brachypodium hereafter) to F. pseudograminearum infection using RNA-seq to determin
288 t necessarily weak binding of tropomyosin to F-actin is required for effective thin filament function
290 016, neurotoxigenic Clostridium baratii type F caused 18 (<0.5%) reported US infant botulism cases.
292 myosin motor domain that are triggered upon F-actin binding and contribute critically to the mechano
294 with the conformational change in the viral F protein that is required to elicit membrane fusion.
295 ate that isolated TM domains of Hendra virus F protein associate in a monomer-trimer equilibrium (Smi
298 e describe the interaction of myosin-5B with F-actin, nucleotides, and the pyrazolopyrimidine compoun
299 he relationship between Tau-PET imaging with F(18)-AV1451 and functional connectivity MRI (fcMRI) in
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。